Journal Section:
Research Report
References
1.
Farhoudi M, Mehrvar K, Afrasiabi A, et al.: Neurocognitive impairment after off-pump and on-pump coronary artery bypass graft surgery: an Iranian experience. Neuropsychiatr Dis Treat 2010;6:775-778.
[PubMed]
2.
Arrowsmith JE, Grocott HP, Reves JG, Newman MF: Central nervous system complications of cardiac surgery. Br J Anaesth 2000;84:378-393.
[PubMed]
3.
Merino JG, Latour LL, Tso A, et al.: Blood-brain barrier disruption after cardiac surgery. AJNR Am J Neuroradiol 2013;34:518-523.
[PubMed]
4.
Gilmore ML, Wolfe DJ: Antipsychotic prophylaxis in surgical patients modestly decreases delirium incidence - but not duration - in high-incidence samples: a meta-analysis. Gen Hosp Psychiatry 2013;35:370-375.
[PubMed]
5.
Sampson EL, Raven PR, Ndhlovu PN, et al.: A randomized, double-blind, placebo-controlled trial of donepezil hydrochloride (Aricept) for reducing the incidence of postoperative delirium after elective total hip replacement. Int Journal Geriatr Psychiatry 2007;22:343-349.
[PubMed]
6.
Campbell N, Boustani MA, Ayub A, et al.: Pharmacological management of delirium in hospitalized adult: a systematic evidence review. J Gen Intern Med 2009;24:848-853.
[PubMed]
7.
Kalisvaart KJ, De Jonghe JFM, Bogaards MJ, et al.: Haloperidol prophylaxis for elderly hip-surgery patients at risk for delirium: a randomized placebo-controlled study. J Am Geriatr Soc 2005;53:1658-1666.
[PubMed]
8.
Gamberini M, Bolliger D, Buse GAL, et al.: Rivastigmine for the prevention of postoperative delirium in elderly patients undergoing elective cardiac surgery - a randomized controlled trial. Crit Care Med 2009;37:1762-1768.
[PubMed]
9.
Pisani MA, Murphy TE, Araujo KLB, Van Ness PH: Factors associated with persistent delirium after intensive care unit admission in an older medical patient population. J Critical Care 2010;25:540:e1-e7.
[PubMed]
10.
Figueroa-Ramos MI, Arroyo-Novoa CM, Lee KA, Padilla G, Puntillo KA: Sleep and delirium in ICU patients: a review of mechanisms and manifestations. Intensive Care Med 2009;35:781-795.
[PubMed]
11.
Baumgartner WA: Neurocognitive changes after coronary bypass surgery. Circulation 2007;116:1879-1881.
[PubMed]
12.
Peng L, Xu L, Ouyang W: Role of peripheral inflammatory markers in postoperative delirium (POCD): a meta-analysis. PloS One 2013;8:e79624.
[PubMed]
13.
Gorelick PB: Role of inflammation in cognitive impairment: results of observational epidemiological studies and clinical trials. Ann N Y Acad Sci 2010;1207:155-162.
[PubMed]
14.
Muralidharan P, Balamurugan G, Babu V: Cerebroprotective effect of Glycyrrhiza glabra Linn. root extract. Bangladesh J Pharmacol 2008;4:60-64.
15.
Yu X-Q, Xue CC, Zhou Z-W, et al.: In vitro and in vivo neuroprotective effect and mechanisms of glabridin, a major active isoflavan from Glycyrrhiza glabra (G. glabra). Life Sci 2008;82:68-78.
[PubMed]
16.
Ojha S, Golechha M, Kumari S, Bhatia J, Arya DS: Glycyrrhiza glabra protects from myocardial ischemia-reperfusion injury by improving hemodynamic, biochemical, histopathological and ventricular function. Exp Toxicol Pathol 2013;65:219-227.
[PubMed]
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently...
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2014
You do not currently have access to this content.
